English
简体中文
Total: £ 56.28
Published Date: 2026-01-30 | Pages: 121 | Tables: 124 | Pharma & Healthcare
The global Coccidiosis Vaccines in Chickens market was valued at US$ 192 million in 2025 and is anticipated to reach US$ 293 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Coccidiosis Vaccines in Chickens competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Coccidiosis vaccines for chickens are immunological preparations designed to protect poultry from coccidiosis, a parasitic disease caused by protozoan parasites belonging to the genus Eimeria. These vaccines work by introducing attenuated or live strains of Eimeria species into the chicken's system, stimulating an immune response that helps the birds develop immunity against future infections.
In China, more than 2.5 billion doses of poultry coccidiosis vaccines are used annually, covering over one-sixth of the total broiler output. The value per dose ranges from RMB 0.05 to 0.08, corresponding to an annual market size of over RMB 150 million. China accounts for approximately 24% of the global market, which exceeds RMB 700 million in total value. The net profit margin for coccidiosis vaccines is around 36%, with a gross margin between 55% and 65%. Over the next five years, the chicken coccidiosis vaccine market is expected to maintain growth, with a compound annual growth rate (CAGR) exceeding 6.1%. This growth momentum is driven by several factors, including rising demand for effective vaccines, technological innovations, supportive policies, and an increasing focus on reducing antibiotic use in the poultry industry.
In terms of vaccine types, tetravalent vaccines are gradually replacing trivalent vaccines and becoming the mainstream in the market. Domestic companies such as Foshan Zhengdian, Qilu Qingda, Tianjin Heliante, and Xi’an Skydar play significant roles, with their products widely used in large-scale poultry farms. Globally, Merck (MSD Animal Health) is a leading international brand, known for its broad-spectrum coverage of Eimeria species, although its expansion in the Chinese market faces challenges such as pricing, registration, and clinical trial pathways. Tetravalent vaccines, which target more Eimeria species, are expected to further replace traditional trivalent vaccines in the future.
In China, coccidiosis vaccines are mainly available in 1,000-dose and 2,000-dose bottles, usually sold in boxes of 10 bottles. The retail price is approximately RMB 80/160 per bottle, translating to RMB 800/1,600 per box. Equivalent products from international leaders such as Merck, Boehringer Ingelheim, and HIPRA are priced 20–40% higher. The tetravalent live vaccine produced by Zhengdian Biotech contains four attenuated Eimeria species: E. tenella, E. necatrix, E. maxima, and E. acervulina. Immunity develops about 14 days post-vaccination and lasts through the end of the rearing cycle. Merck’s breeder chicken vaccine contains strong strains of eight Eimeria species: E. maxima, E. acervulina, E. tenella, E. mitis, E. necatrix, E. brunetti, E. praecox, and E. hagani.
This report delivers a comprehensive overview of the global Coccidiosis Vaccines in Chickens market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Coccidiosis Vaccines in Chickens. The Coccidiosis Vaccines in Chickens market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Coccidiosis Vaccines in Chickens market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Coccidiosis Vaccines in Chickens manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
MSD Animal Health
Boehringer Ingelheim
HIPRA
Bioproperties
Huvepharma
Nisseiken
Biopharm
Ceva Santé Animale
Vaxxinova
Hlinte
Foshan Standard Biotech
Qilu Qingda Bio-Pharmaceutical
Skystar Bio-pharm
Guangdong Winsun Bio-pharmaceutical
Segment by Type
Attenuated Vaccines
Non-attenuated Vaccines
by Application
Breeders
Layers
Broilers
Turkeys
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Coccidiosis Vaccines in Chickens manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Coccidiosis Vaccines in Chickens sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Coccidiosis Vaccines in Chickens Market Overview
1.1 Product Definition
1.2 Coccidiosis Vaccines in Chickens by Type
1.2.1 Global Coccidiosis Vaccines in Chickens Market Value by Type: 2025 vs 2032
1.2.2 Attenuated Vaccines
1.2.3 Non-attenuated Vaccines
1.3 Coccidiosis Vaccines in Chickens by Application
1.3.1 Global Coccidiosis Vaccines in Chickens Market Value by Application: 2025 vs 2032
1.3.2 Breeders
1.3.3 Layers
1.3.4 Broilers
1.3.5 Turkeys
1.4 Global Coccidiosis Vaccines in Chickens Market Size Estimates and Forecasts
1.4.1 Global Coccidiosis Vaccines in Chickens Revenue 2021–2032
1.4.2 Global Coccidiosis Vaccines in Chickens Sales 2021–2032
1.4.3 Global Coccidiosis Vaccines in Chickens Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Coccidiosis Vaccines in Chickens Market Competition by Manufacturers
2.1 Global Coccidiosis Vaccines in Chickens Sales Market Share by Manufacturers (2021–2026)
2.2 Global Coccidiosis Vaccines in Chickens Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Coccidiosis Vaccines in Chickens Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Coccidiosis Vaccines in Chickens, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Coccidiosis Vaccines in Chickens, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Coccidiosis Vaccines in Chickens, Product Types and Applications
2.7 Global Key Manufacturers of Coccidiosis Vaccines in Chickens, Date of Entry into the Industry
2.8 Global Coccidiosis Vaccines in Chickens Market Competitive Situation and Trends
2.8.1 Global Coccidiosis Vaccines in Chickens Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Coccidiosis Vaccines in Chickens Players Market Share by Revenue
2.8.3 Global Coccidiosis Vaccines in Chickens Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Coccidiosis Vaccines in Chickens Market Scenario by Region
3.1 Global Coccidiosis Vaccines in Chickens Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Coccidiosis Vaccines in Chickens Sales by Region: 2021–2032
3.2.1 Global Coccidiosis Vaccines in Chickens Sales by Region: 2021–2026
3.2.2 Global Coccidiosis Vaccines in Chickens Sales by Region: 2027–2032
3.3 Global Coccidiosis Vaccines in Chickens Revenue by Region: 2021–2032
3.3.1 Global Coccidiosis Vaccines in Chickens Revenue by Region: 2021–2026
3.3.2 Global Coccidiosis Vaccines in Chickens Revenue by Region: 2027–2032
3.4 North America Coccidiosis Vaccines in Chickens Market Facts & Figures by Country
3.4.1 North America Coccidiosis Vaccines in Chickens Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Coccidiosis Vaccines in Chickens Sales by Country (2021–2032)
3.4.3 North America Coccidiosis Vaccines in Chickens Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Coccidiosis Vaccines in Chickens Market Facts & Figures by Country
3.5.1 Europe Coccidiosis Vaccines in Chickens Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Coccidiosis Vaccines in Chickens Sales by Country (2021–2032)
3.5.3 Europe Coccidiosis Vaccines in Chickens Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coccidiosis Vaccines in Chickens Market Facts & Figures by Region
3.6.1 Asia Pacific Coccidiosis Vaccines in Chickens Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Coccidiosis Vaccines in Chickens Sales by Region (2021–2032)
3.6.3 Asia Pacific Coccidiosis Vaccines in Chickens Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Coccidiosis Vaccines in Chickens Market Facts & Figures by Country
3.7.1 Latin America Coccidiosis Vaccines in Chickens Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Coccidiosis Vaccines in Chickens Sales by Country (2021–2032)
3.7.3 Latin America Coccidiosis Vaccines in Chickens Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Coccidiosis Vaccines in Chickens Market Facts & Figures by Country
3.8.1 Middle East and Africa Coccidiosis Vaccines in Chickens Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Coccidiosis Vaccines in Chickens Sales by Country (2021–2032)
3.8.3 Middle East and Africa Coccidiosis Vaccines in Chickens Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coccidiosis Vaccines in Chickens Sales by Type (2021–2032)
4.1.1 Global Coccidiosis Vaccines in Chickens Sales by Type (2021–2026)
4.1.2 Global Coccidiosis Vaccines in Chickens Sales by Type (2027–2032)
4.1.3 Global Coccidiosis Vaccines in Chickens Sales Market Share by Type (2021–2032)
4.2 Global Coccidiosis Vaccines in Chickens Revenue by Type (2021–2032)
4.2.1 Global Coccidiosis Vaccines in Chickens Revenue by Type (2021–2026)
4.2.2 Global Coccidiosis Vaccines in Chickens Revenue by Type (2027–2032)
4.2.3 Global Coccidiosis Vaccines in Chickens Revenue Market Share by Type (2021–2032)
4.3 Global Coccidiosis Vaccines in Chickens Price by Type (2021–2032)
5 Segment by Application
5.1 Global Coccidiosis Vaccines in Chickens Sales by Application (2021–2032)
5.1.1 Global Coccidiosis Vaccines in Chickens Sales by Application (2021–2026)
5.1.2 Global Coccidiosis Vaccines in Chickens Sales by Application (2027–2032)
5.1.3 Global Coccidiosis Vaccines in Chickens Sales Market Share by Application (2021–2032)
5.2 Global Coccidiosis Vaccines in Chickens Revenue by Application (2021–2032)
5.2.1 Global Coccidiosis Vaccines in Chickens Revenue by Application (2021–2026)
5.2.2 Global Coccidiosis Vaccines in Chickens Revenue by Application (2027–2032)
5.2.3 Global Coccidiosis Vaccines in Chickens Revenue Market Share by Application (2021–2032)
5.3 Global Coccidiosis Vaccines in Chickens Price by Application (2021–2032)
6 Key Companies Profiled
6.1 MSD Animal Health
6.1.1 MSD Animal Health Company Information
6.1.2 MSD Animal Health Description and Business Overview
6.1.3 MSD Animal Health Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 MSD Animal Health Coccidiosis Vaccines in Chickens Product Portfolio
6.1.5 MSD Animal Health Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boehringer Ingelheim Coccidiosis Vaccines in Chickens Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 HIPRA
6.3.1 HIPRA Company Information
6.3.2 HIPRA Description and Business Overview
6.3.3 HIPRA Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 HIPRA Coccidiosis Vaccines in Chickens Product Portfolio
6.3.5 HIPRA Recent Developments/Updates
6.4 Bioproperties
6.4.1 Bioproperties Company Information
6.4.2 Bioproperties Description and Business Overview
6.4.3 Bioproperties Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bioproperties Coccidiosis Vaccines in Chickens Product Portfolio
6.4.5 Bioproperties Recent Developments/Updates
6.5 Huvepharma
6.5.1 Huvepharma Company Information
6.5.2 Huvepharma Description and Business Overview
6.5.3 Huvepharma Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Huvepharma Coccidiosis Vaccines in Chickens Product Portfolio
6.5.5 Huvepharma Recent Developments/Updates
6.6 Nisseiken
6.6.1 Nisseiken Company Information
6.6.2 Nisseiken Description and Business Overview
6.6.3 Nisseiken Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Nisseiken Coccidiosis Vaccines in Chickens Product Portfolio
6.6.5 Nisseiken Recent Developments/Updates
6.7 Biopharm
6.7.1 Biopharm Company Information
6.7.2 Biopharm Description and Business Overview
6.7.3 Biopharm Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Biopharm Coccidiosis Vaccines in Chickens Product Portfolio
6.7.5 Biopharm Recent Developments/Updates
6.8 Ceva Santé Animale
6.8.1 Ceva Santé Animale Company Information
6.8.2 Ceva Santé Animale Description and Business Overview
6.8.3 Ceva Santé Animale Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Ceva Santé Animale Coccidiosis Vaccines in Chickens Product Portfolio
6.8.5 Ceva Santé Animale Recent Developments/Updates
6.9 Vaxxinova
6.9.1 Vaxxinova Company Information
6.9.2 Vaxxinova Description and Business Overview
6.9.3 Vaxxinova Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Vaxxinova Coccidiosis Vaccines in Chickens Product Portfolio
6.9.5 Vaxxinova Recent Developments/Updates
6.10 Hlinte
6.10.1 Hlinte Company Information
6.10.2 Hlinte Description and Business Overview
6.10.3 Hlinte Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Hlinte Coccidiosis Vaccines in Chickens Product Portfolio
6.10.5 Hlinte Recent Developments/Updates
6.11 Foshan Standard Biotech
6.11.1 Foshan Standard Biotech Company Information
6.11.2 Foshan Standard Biotech Description and Business Overview
6.11.3 Foshan Standard Biotech Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Foshan Standard Biotech Coccidiosis Vaccines in Chickens Product Portfolio
6.11.5 Foshan Standard Biotech Recent Developments/Updates
6.12 Qilu Qingda Bio-Pharmaceutical
6.12.1 Qilu Qingda Bio-Pharmaceutical Company Information
6.12.2 Qilu Qingda Bio-Pharmaceutical Description and Business Overview
6.12.3 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio
6.12.5 Qilu Qingda Bio-Pharmaceutical Recent Developments/Updates
6.13 Skystar Bio-pharm
6.13.1 Skystar Bio-pharm Company Information
6.13.2 Skystar Bio-pharm Description and Business Overview
6.13.3 Skystar Bio-pharm Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Skystar Bio-pharm Coccidiosis Vaccines in Chickens Product Portfolio
6.13.5 Skystar Bio-pharm Recent Developments/Updates
6.14 Guangdong Winsun Bio-pharmaceutical
6.14.1 Guangdong Winsun Bio-pharmaceutical Company Information
6.14.2 Guangdong Winsun Bio-pharmaceutical Description and Business Overview
6.14.3 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio
6.14.5 Guangdong Winsun Bio-pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coccidiosis Vaccines in Chickens Industry Chain Analysis
7.2 Coccidiosis Vaccines in Chickens Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coccidiosis Vaccines in Chickens Production Mode & Process Analysis
7.4 Coccidiosis Vaccines in Chickens Sales and Marketing
7.4.1 Coccidiosis Vaccines in Chickens Sales Channels
7.4.2 Coccidiosis Vaccines in Chickens Distributors
7.5 Coccidiosis Vaccines in Chickens Customer Analysis
8 Coccidiosis Vaccines in Chickens Market Dynamics
8.1 Coccidiosis Vaccines in Chickens Industry Trends
8.2 Coccidiosis Vaccines in Chickens Market Drivers
8.3 Coccidiosis Vaccines in Chickens Market Challenges
8.4 Coccidiosis Vaccines in Chickens Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Coccidiosis Vaccines in Chickens Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Coccidiosis Vaccines in Chickens Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Coccidiosis Vaccines in Chickens Market Competitive Situation by Manufacturers in 2025
Table 4. Global Coccidiosis Vaccines in Chickens Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Coccidiosis Vaccines in Chickens Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Coccidiosis Vaccines in Chickens Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Coccidiosis Vaccines in Chickens Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Coccidiosis Vaccines in Chickens Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Coccidiosis Vaccines in Chickens, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Coccidiosis Vaccines in Chickens, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Coccidiosis Vaccines in Chickens, Product Types and Applications
Table 12. Global Key Manufacturers of Coccidiosis Vaccines in Chickens, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Coccidiosis Vaccines in Chickens Companies by Tier (Tier 1, Tier 2, Tier 3), based on Coccidiosis Vaccines in Chickens Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Coccidiosis Vaccines in Chickens Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Coccidiosis Vaccines in Chickens Sales by Region (K Units), 2021–2026
Table 18. Global Coccidiosis Vaccines in Chickens Sales Market Share by Region (2021–2026)
Table 19. Global Coccidiosis Vaccines in Chickens Sales by Region (K Units), 2027–2032
Table 20. Global Coccidiosis Vaccines in Chickens Sales Market Share by Region (2027–2032)
Table 21. Global Coccidiosis Vaccines in Chickens Revenue by Region (US$ Million), 2021–2026
Table 22. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Region (2021–2026)
Table 23. Global Coccidiosis Vaccines in Chickens Revenue by Region (US$ Million), 2027–2032
Table 24. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Region (2027–2032)
Table 25. North America Coccidiosis Vaccines in Chickens Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Coccidiosis Vaccines in Chickens Sales by Country (K Units), 2021–2026
Table 27. North America Coccidiosis Vaccines in Chickens Sales by Country (K Units), 2027–2032
Table 28. North America Coccidiosis Vaccines in Chickens Revenue by Country (US$ Million), 2021–2026
Table 29. North America Coccidiosis Vaccines in Chickens Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Coccidiosis Vaccines in Chickens Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Coccidiosis Vaccines in Chickens Sales by Country (K Units), 2021–2026
Table 32. Europe Coccidiosis Vaccines in Chickens Sales by Country (K Units), 2027–2032
Table 33. Europe Coccidiosis Vaccines in Chickens Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Coccidiosis Vaccines in Chickens Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Coccidiosis Vaccines in Chickens Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Coccidiosis Vaccines in Chickens Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Coccidiosis Vaccines in Chickens Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Coccidiosis Vaccines in Chickens Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Coccidiosis Vaccines in Chickens Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Coccidiosis Vaccines in Chickens Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Coccidiosis Vaccines in Chickens Sales by Country (K Units), 2021–2026
Table 42. Latin America Coccidiosis Vaccines in Chickens Sales by Country (K Units), 2027–2032
Table 43. Latin America Coccidiosis Vaccines in Chickens Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Coccidiosis Vaccines in Chickens Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Coccidiosis Vaccines in Chickens Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Coccidiosis Vaccines in Chickens Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Coccidiosis Vaccines in Chickens Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Coccidiosis Vaccines in Chickens Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Coccidiosis Vaccines in Chickens Revenue by Country (US$ Million), 2027–2032
Table 50. Global Coccidiosis Vaccines in Chickens Sales (K Units) by Type (2021–2026)
Table 51. Global Coccidiosis Vaccines in Chickens Sales (K Units) by Type (2027–2032)
Table 52. Global Coccidiosis Vaccines in Chickens Sales Market Share by Type (2021–2026)
Table 53. Global Coccidiosis Vaccines in Chickens Sales Market Share by Type (2027–2032)
Table 54. Global Coccidiosis Vaccines in Chickens Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Coccidiosis Vaccines in Chickens Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Type (2021–2026)
Table 57. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Type (2027–2032)
Table 58. Global Coccidiosis Vaccines in Chickens Price (US$/Unit) by Type (2021–2026)
Table 59. Global Coccidiosis Vaccines in Chickens Price (US$/Unit) by Type (2027–2032)
Table 60. Global Coccidiosis Vaccines in Chickens Sales (K Units) by Application (2021–2026)
Table 61. Global Coccidiosis Vaccines in Chickens Sales (K Units) by Application (2027–2032)
Table 62. Global Coccidiosis Vaccines in Chickens Sales Market Share by Application (2021–2026)
Table 63. Global Coccidiosis Vaccines in Chickens Sales Market Share by Application (2027–2032)
Table 64. Global Coccidiosis Vaccines in Chickens Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Coccidiosis Vaccines in Chickens Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Application (2021–2026)
Table 67. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Application (2027–2032)
Table 68. Global Coccidiosis Vaccines in Chickens Price (US$/Unit) by Application (2021–2026)
Table 69. Global Coccidiosis Vaccines in Chickens Price (US$/Unit) by Application (2027–2032)
Table 70. MSD Animal Health Company Information
Table 71. MSD Animal Health Description and Business Overview
Table 72. MSD Animal Health Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. MSD Animal Health Coccidiosis Vaccines in Chickens Product
Table 74. MSD Animal Health Recent Developments/Updates
Table 75. Boehringer Ingelheim Company Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Boehringer Ingelheim Coccidiosis Vaccines in Chickens Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. HIPRA Company Information
Table 81. HIPRA Description and Business Overview
Table 82. HIPRA Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. HIPRA Coccidiosis Vaccines in Chickens Product
Table 84. HIPRA Recent Developments/Updates
Table 85. Bioproperties Company Information
Table 86. Bioproperties Description and Business Overview
Table 87. Bioproperties Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Bioproperties Coccidiosis Vaccines in Chickens Product
Table 89. Bioproperties Recent Developments/Updates
Table 90. Huvepharma Company Information
Table 91. Huvepharma Description and Business Overview
Table 92. Huvepharma Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Huvepharma Coccidiosis Vaccines in Chickens Product
Table 94. Huvepharma Recent Developments/Updates
Table 95. Nisseiken Company Information
Table 96. Nisseiken Description and Business Overview
Table 97. Nisseiken Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Nisseiken Coccidiosis Vaccines in Chickens Product
Table 99. Nisseiken Recent Developments/Updates
Table 100. Biopharm Company Information
Table 101. Biopharm Description and Business Overview
Table 102. Biopharm Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Biopharm Coccidiosis Vaccines in Chickens Product
Table 104. Biopharm Recent Developments/Updates
Table 105. Ceva Santé Animale Company Information
Table 106. Ceva Santé Animale Description and Business Overview
Table 107. Ceva Santé Animale Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Ceva Santé Animale Coccidiosis Vaccines in Chickens Product
Table 109. Ceva Santé Animale Recent Developments/Updates
Table 110. Vaxxinova Company Information
Table 111. Vaxxinova Description and Business Overview
Table 112. Vaxxinova Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Vaxxinova Coccidiosis Vaccines in Chickens Product
Table 114. Vaxxinova Recent Developments/Updates
Table 115. Hlinte Company Information
Table 116. Hlinte Description and Business Overview
Table 117. Hlinte Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Hlinte Coccidiosis Vaccines in Chickens Product
Table 119. Hlinte Recent Developments/Updates
Table 120. Foshan Standard Biotech Company Information
Table 121. Foshan Standard Biotech Description and Business Overview
Table 122. Foshan Standard Biotech Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Foshan Standard Biotech Coccidiosis Vaccines in Chickens Product
Table 124. Foshan Standard Biotech Recent Developments/Updates
Table 125. Qilu Qingda Bio-Pharmaceutical Company Information
Table 126. Qilu Qingda Bio-Pharmaceutical Description and Business Overview
Table 127. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Product
Table 129. Qilu Qingda Bio-Pharmaceutical Recent Developments/Updates
Table 130. Skystar Bio-pharm Company Information
Table 131. Skystar Bio-pharm Description and Business Overview
Table 132. Skystar Bio-pharm Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Skystar Bio-pharm Coccidiosis Vaccines in Chickens Product
Table 134. Skystar Bio-pharm Recent Developments/Updates
Table 135. Guangdong Winsun Bio-pharmaceutical Company Information
Table 136. Guangdong Winsun Bio-pharmaceutical Description and Business Overview
Table 137. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Product
Table 139. Guangdong Winsun Bio-pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Coccidiosis Vaccines in Chickens Distributors List
Table 143. Coccidiosis Vaccines in Chickens Customers List
Table 144. Coccidiosis Vaccines in Chickens Market Trends
Table 145. Coccidiosis Vaccines in Chickens Market Drivers
Table 146. Coccidiosis Vaccines in Chickens Market Challenges
Table 147. Coccidiosis Vaccines in Chickens Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Coccidiosis Vaccines in Chickens
Figure 2. Global Coccidiosis Vaccines in Chickens Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Coccidiosis Vaccines in Chickens Market Share by Type: 2025 & 2032
Figure 4. Attenuated Vaccines Product Picture
Figure 5. Non-attenuated Vaccines Product Picture
Figure 6. Global Coccidiosis Vaccines in Chickens Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Coccidiosis Vaccines in Chickens Market Share by Application: 2025 & 2032
Figure 8. Breeders
Figure 9. Layers
Figure 10. Broilers
Figure 11. Turkeys
Figure 12. Global Coccidiosis Vaccines in Chickens Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Coccidiosis Vaccines in Chickens Market Size (US$ Million), 2021–2032
Figure 14. Global Coccidiosis Vaccines in Chickens Sales (K Units), 2021–2032
Figure 15. Global Coccidiosis Vaccines in Chickens Average Price (US$/Unit), 2021–2032
Figure 16. Coccidiosis Vaccines in Chickens Report Years Considered
Figure 17. Coccidiosis Vaccines in Chickens Sales Share by Manufacturers in 2025
Figure 18. Global Coccidiosis Vaccines in Chickens Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Coccidiosis Vaccines in Chickens Players: Market Share by Revenue in Coccidiosis Vaccines in Chickens in 2025
Figure 20. Coccidiosis Vaccines in Chickens Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Coccidiosis Vaccines in Chickens Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021–2032)
Figure 23. North America Coccidiosis Vaccines in Chickens Revenue Market Share by Country (2021–2032)
Figure 24. United States Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021–2032)
Figure 27. Europe Coccidiosis Vaccines in Chickens Revenue Market Share by Country (2021–2032)
Figure 28. Germany Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Coccidiosis Vaccines in Chickens Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Coccidiosis Vaccines in Chickens Revenue Market Share by Region (2021–2032)
Figure 35. China Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021–2032)
Figure 43. Latin America Coccidiosis Vaccines in Chickens Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Coccidiosis Vaccines in Chickens Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Coccidiosis Vaccines in Chickens Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Coccidiosis Vaccines in Chickens by Type (2021–2032)
Figure 54. Global Revenue Market Share of Coccidiosis Vaccines in Chickens by Type (2021–2032)
Figure 55. Global Coccidiosis Vaccines in Chickens Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Coccidiosis Vaccines in Chickens by Application (2021–2032)
Figure 57. Global Revenue Market Share of Coccidiosis Vaccines in Chickens by Application (2021–2032)
Figure 58. Global Coccidiosis Vaccines in Chickens Price (US$/Unit) by Application (2021–2032)
Figure 59. Coccidiosis Vaccines in Chickens Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
